Sravathi AI: One Stop-Shop for End-to-End Drug Discovery Solutions
The use of Low-Code and No-Code platforms in pharmaceutical industry is expanding at a fast pace across the globe. India has the potential to grow and generate 4 billion dollar in revenue by the year 2025 from the Low-Code and No-Code market, accounting for 10 percent of the global market share. Nowadays, there are very less number of innovations taking place in this sector due to lack of quality software solutions. Condition on the clients’ side is totally different as they are expecting for quicker and easier trials so that end product can reach to the market in a lower turnaround time. Sravathi AI is an emerging firm that is adopting sophisticated artificial intelligence practices as they have the potential to spur some powerful innovations in Drug Discovery and Chemistry AI platforms. It is a young company that is involved in the scientific discovery and creation of drug molecules, chemicals, formulations, chemical reactions, polymers, catalysts, and other materials.Located in Bangalore, Sravathi AI is an artificial intelligence based startup that is creating, discovering and developing innovative and advanced pharmaceutical and chemical products. The company performs these operations in close association with internal and external partner companies especially in the areas of chemical synthesis, property measurement, in-vitro screening and clinical trials. “We have shown to the world that a small startup like us can take head-on technology challenges, perform end to end operations in terms of discovery of molecules with the help of artificial intelligence, followed by lab work and biological testing”, says Dr. Kishan Gurram, MD & CEO.
Proficient in Generating New Molecules
Sravathi AI uses hybrid intelligence through which it combines the brilliance of the human mind and domain expertise with innovative technology. This technology is based on artificial intelligence and it helps to solve some of the most difficult problems of the chemical and drug industry. The company has also done more dynamic simulations and predictions which is typically rare in this
sector. The company has a built up facility of around 15000 square feet and can easily embrace strength of 100 employees. Currently, Sravathi AI has a team of around 50 researchers of multi-disciplinary competencies with decades of experience.
Sravathi AI has developed in house algorithms based on artificial intelligence that can make accurate predictions involving the vast and unexplored space of molecules and chemical reactions. Eventually, it can reduce uncertainty in the drug discovery process, saving time and costs during development. Sravathi’s artificial intelligence solution is a platform of predictive models, optimization frameworks and an active learning workflow. Despite being an MSME, the firm is playing a major role in accelerating drug discovery, drug re-purposing and Protein Degradation (PROTAC).
Sravathi AI has shown to everyone that drug discovery and development is accessible and affordable to every small company because in India today no major company is doing complete drug discovery at all. Only big global innovator companies are doing it because of affordability, chances of success and time taken by it. The current pipeline of the company primarily consists of deep learning driven New Chemical Entity, reaction optimization, formulations, and allied areas. Sravathi AI has come up with entire chemistry AI platform which is unique and first of its kind. This helps entire Pharma and other chemical sectors to reduce their R&D time and expenditure by order of magnitude.
Along with expanding its capabilities within India, Sravathi AI is planning to setup one of its offices in US as well because lots of its customers are from US and Europe. Looking into the future, the company has plans to expand in the areas of analytical AI, chemical AI, biological large molecule discovery, protein degradation and re-purposing of drugs. Sravathi AI is looking ahead to become advanced process innovator globally with proficiency in pharmaceuticals, fine chemicals, high value chemicals, petrochemicals, agro chemicals, and more.
Sravathi AI has developed in house algorithms based on artificial intelligence that can make accurate predictions involving the vast and unexplored space of molecules and chemical reactions. Eventually, it can reduce uncertainty in the drug discovery process, saving time and costs during development. Sravathi’s artificial intelligence solution is a platform of predictive models, optimization frameworks and an active learning workflow. Despite being an MSME, the firm is playing a major role in accelerating drug discovery, drug re-purposing and Protein Degradation (PROTAC).
The firm is deeply involved to address the diverse needs of people using AI through the provision of pharmaceuticals & other chemicals
Sravathi AI has shown to everyone that drug discovery and development is accessible and affordable to every small company because in India today no major company is doing complete drug discovery at all. Only big global innovator companies are doing it because of affordability, chances of success and time taken by it. The current pipeline of the company primarily consists of deep learning driven New Chemical Entity, reaction optimization, formulations, and allied areas. Sravathi AI has come up with entire chemistry AI platform which is unique and first of its kind. This helps entire Pharma and other chemical sectors to reduce their R&D time and expenditure by order of magnitude.
Along with expanding its capabilities within India, Sravathi AI is planning to setup one of its offices in US as well because lots of its customers are from US and Europe. Looking into the future, the company has plans to expand in the areas of analytical AI, chemical AI, biological large molecule discovery, protein degradation and re-purposing of drugs. Sravathi AI is looking ahead to become advanced process innovator globally with proficiency in pharmaceuticals, fine chemicals, high value chemicals, petrochemicals, agro chemicals, and more.
